Market Analysis of Diabetic Products

Diabetes care market encompasses of technologies, devices and therapeutics in relative to diabetes. There has been a substantial increase in the amount of diabetes cases internationally over the last few years. Currently, about millions of people are in misery because of obesity, which is a key reason for increase of diabetes in people. Key Players profiled in the report include Glaxosmithkline, Novo Nordisk, Roche, Medtronicand etc. Novo Nordisk is a leading global provider of diabetes products. The company also has a headship spot in hemostasis management, growth hormone therapy and hormone replacement therapy. The company progresses, manufactures and markets its medical devices and technologies to hospitals, doctors, researchers, scientists and patients in approximately 160 countries.

  • Hormone replacement therapy
  • Blood glucose monitoring system
  • Smart insulin
  • Timesulin
  • Insulin Powder

Related Conference of Market Analysis of Diabetic Products

July 17-18, 2017

18th European Diabetes Congress

Lisbon, Portugal
July 20-22, 2017

19thAsia Pacific Diabetes Conference

Melbourne, Australia
July 24-26,2017

10th Diabetologists Conference

Vancouver, Canada
September 11-12, 2017

9th Annual Congress on Endocrine Disorders and Therapies


(10 Plenary Forums - 1 Event)
Dallas, Texas, USA
September 20-22, 2017

International Conference on Diabetes and Diabetic Nursing Care

Charlotte, North Carolina, USA
October 30-November 01, 2017

10th International Conference on Endocrinology

Chicago, Illinois, USA
December 11-12, 2017

25th Global Diabetes Summit and Medicare Expo

Dubai, UAE
February 12-13,2018

7th European Diabetes and Endocrinology Congress

Munich, Germany
March 08-09, 2018

17th Global Diabetes Conference and Medicare Expo

Paris, France

Market Analysis of Diabetic Products Conference Speakers

Recommended Sessions

Related Journals

Are you interested in